The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

58 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
4
Formosusin A, a novel specific inhibitor of mammalian DNA polymeraseß from the fungus Paecilomyces formosus.EBI
Kobe Gakuin University
13
Design and Discovery of 2-Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases.EBI
University of Bath
40
Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.EBI
Brandeis University
12
Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure.EBI
University of Minnesota
4
Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.EBI
TBA
45
Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.EBI
Brandeis University
5
Penicacids A-C, three new mycophenolic acid derivatives and immunosuppressive activities from the marine-derived fungus Penicillium sp. SOF07.EBI
Chinese Academy of Sciences
3
Pinophilins A and B, inhibitors of mammalian A-, B-, and Y-family DNA polymerases and human cancer cell proliferation.EBI
Science University of Tokyo
38
Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH.EBI
Brandeis University
2
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.EBI
Kyoto Prefectural University
23
Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.EBI
Brandeis University
7
Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.EBI
Pharmasset
24
Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity.EBI
TBA
2
Synthesis of a methylenebis(phosphonate) analogue of mycophenolic adenine dinucleotide: a glucuronidation-resistant MAD analogue of NAD.EBI
Codon Pharmaceuticals
5
Isosteric analogues of nicotinamide adenine dinucleotide derived from furanfurin, thiophenfurin, and selenophenfurin as mammalian inosine monophosphate dehydrogenase (type I and II) inhibitors.EBI
University of Camerino
9
Synthesis of nonhydrolyzable analogues of thiazole-4-carboxamide and benzamide adenine dinucleotide containing fluorine atom at the C2' of adenine nucleoside: induction of K562 differentiation and inosine monophosphate dehydrogenase inhibitory activity.EBI
Codon Pharmaceuticals
10
Rationally designed inhibitors of inosine monophosphate dehydrogenase.EBI
University of Chicago
6
The design, synthesis and in vitro immunosuppressive evaluation of novel isobenzofuran derivatives.EBI
Shenyang Pharmaceutical University
3
Aminothiazoles as¿-secretase modulators.EBI
F. Hoffmann-La Roche
20
Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.EBI
University of Minnesota
7
Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.EBI
Hokkaido University
4
Triazole-linked inhibitors of inosine monophosphate dehydrogenase from human and Mycobacterium tuberculosis.EBI
University of Minnesota
6
Mycophenolic acid analogs with a modified metabolic profile.EBI
University of Minnesota
13
Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase.EBI
University of Minnesota
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.EBI
Johann Wolfgang Goethe University
7
Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment.EBI
University of Minnesota
1
Methylenebis(sulfonamide) linked nicotinamide adenine dinucleotide analogue as an inosine monophosphate dehydrogenase inhibitor.EBI
University of Minnesota
44
Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer.EBI
Ocean University of China
2
Novel methylenephosphophosphonate analogues of mycophenolic adenine dinucleotide. Inhibition of inosine monophosphate dehydrogenase.EBI
University of Minnesota
19
A closer look at NEBI
Monash University Malaysia
23
Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH.EBI
Gilead Sciences
24
Novel indole inhibitors of IMPDH from fragments: synthesis and initial structure-activity relationships.EBI
Ucb Pharma
15
Low molecular weight indole fragments as IMPDH inhibitors.EBI
Ucb Pharma
21
Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitors.EBI
Ucb Pharma
14
Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationships.EBI
Celltech R and D
36
3-cyanoindole-based inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationships.EBI
Bristol Myers Squibb
49
Inhibitors of inosine monophosphate dehydrogenase: SARs about the N-[3-Methoxy-4-(5-oxazolyl)phenyl moiety.EBI
Bristol Myers Squibb
25
Identification of novel and potent isoquinoline aminooxazole-based IMPDH inhibitors.EBI
Bristol Myers Squibb
13
Novel indole-based inhibitors of IMPDH: introduction of hydrogen bond acceptors at indole C-3.EBI
Bristol Myers Squibb
34
Quinolone-based IMPDH inhibitors: introduction of basic residues on ring D and SAR of the corresponding mono, di and benzofused analogues.EBI
Bristol Myers Squibb
31
Novel inhibitors of IMPDH: a highly potent and selective quinolone-based series.EBI
Bristol Myers Squibb
15
The TosMIC approach to 3-(oxazol-5-yl) indoles: application to the synthesis of indole-based IMPDH inhibitors.EBI
Bristol Myers Squibb
14
A survey of cyclic replacements for the central diamide moiety of inhibitors of inosine monophosphate dehydrogenase.EBI
Bristol Myers Squibb
23
Novel guanidine-based inhibitors of inosine monophosphate dehydrogenase.EBI
Bristol Myers Squibb
39
Novel amide-based inhibitors of inosine 5'-monophosphate dehydrogenase.EBI
Bristol Myers Squibb
30
Rapid synthesis of triazine inhibitors of inosine monophosphate dehydrogenase.EBI
Bristol Myers Squibb
22
Novel diamide-based inhibitors of IMPDH.EBI
Bristol Myers Squibb
17
Mycophenolic anilides as broad specificity inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors.EBI
University of Houston
64
Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase by nuclear variants of mycophenolic acid.EBI
Syntex Research
42
NAD-based inhibitors with anticancer potential.EBI
University of Minnesota
3
Discovery of N-(2,3,5-triazoyl)mycophenolic amide and mycophenolic epoxyketone as novel inhibitors of human IMPDH.EBI
Hokkaido University
9
Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.EBI
Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management
16
Antifungal benzo[b]thiophene 1,1-dioxide IMPDH inhibitors exhibit pan-assay interference (PAINS) profiles.EBI
The University of Queensland
48
Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents.EBI
National Institute of Allergy and Infectious Diseases
64
Bile acid analogs as FXR/TGR5 agonists and methods of use thereofBDB
Enanta Pharmaceuticals
35
Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBDB
Bayer Intellectual Property
23
Novel CDK inhibition profiles of structurally varied 1-aza-9-oxafluorenes.BDB
Martin-Luther-University Halle-Wittenberg
21
Synthesis and anticancer activity of new pyrrolocarbazoles and pyrrolo-beta-carbolines.BDB
Cnrs